Evidence map›Paper›PMID 37466616›Full record

ArticleACS chemical neuroscience2023

An FSCV Study on the Effects of Targeted Typical and Atypical DAT Inhibition on Dopamine Dynamics in the Nucleus Accumbens Shell of Male and Female Mice.

Melinda Hersey, Andy Y Chen, Mattingly K Bartole, Jayati Anand, Amy Hauck Newman, Gianluigi Tanda

Open access · greenAbstract read
In one paragraph

Article in ACS chemical neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  5. Article
  6. Modafinil, an atypical CNS stimulant?Advances in pharmacology (San Diego, Calif.) · 2024
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Melinda HerseyMedication Development Program, NIDA IRP, Baltimore, Maryland 21224, United States.ORCID 0000-0001-6299-9874
Andy Y ChenMedication Development Program, NIDA IRP, Baltimore, Maryland 21224, United States.
Mattingly K BartoleMedication Development Program, NIDA IRP, Baltimore, Maryland 21224, United States.
Jayati AnandMedication Development Program, NIDA IRP, Baltimore, Maryland 21224, United States.
Amy Hauck NewmanMedication Development Program, NIDA IRP, Baltimore, Maryland 21224, United States.ORCID 0000-0001-9065-4072
Gianluigi TandaMedication Development Program, NIDA IRP, Baltimore, Maryland 21224, United States.ORCID 0000-0001-9526-9878
National Institute on Drug Abuse · US

Funding

Investigation On The Behavior And Related Neuro-Electrochemistry Of Potential Medications For The Treatment Of Substance Use Disorders.ZIADA000611 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI TANDA, GIANLUIGI · 2016 to 2025
$16.0M
Novel Probes for the Monoamine TransportersZIADA000389 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI NEWMAN, AMY HAUCK · 2009 to 2025
$14.4M
Intramural NIH HHS ZIA DA000611
6 · The paper itself

Abstract

Understanding the neurochemistry underlying sex differences in psychostimulant use disorders (PSUD) is essential for developing related therapeutics. Many psychostimulants, like cocaine, inhibit the dopamine transporter (DAT), which is largely thought to account for actions related to their misuse and dependence. Cocaine-like, typical DAT inhibitors preferentially bind DAT in an outward-facing conformation, while atypical DAT inhibitors, like modafinil, prefer a more inward-facing DAT conformation. Modafinil and

Indexed as

Central Nervous System StimulantsCocaineAnimalsDopamineDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsFemaleMaleMiceMice, Inbred C57BLModafinilNucleus AccumbensOxalatesPiperazinesCentral Nervous System StimulantsCocaineDopamineDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsJJC8-088JJC8-091ModafinilOxalatesPiperazinesDopaminedopamine transporterFSCVmodafinilsex differencessubstance use disorder

Identifiers

PMID37466616
PMCPMC10766117
OpenAlexW4384663723

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.